Hub : Traits :

Headache pain in last month

420 significantly associated models · 64 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 149672809 151227371 5 1 1.4e-11 6.9e-11 5.1e-01 99 ECM1
2 1 155739430 157168420 1 1 2.7e-10 4.5e-16 3.9e-08 54 MEF2D
3 1 242590540 244359621 3 1 2.8e-09 1.8e-08 1.0e-01 92 CEP170
4 3 157594704 159140638 3 1 6.9e-08 6.9e-08 1.0e+00 100 RARRES1
5 4 87165758 88754060 1 1 1.7e-07 2.3e-08 1.9e-02 82 AFF1
6 6 12020241 13990267 2 1 2.4e-15 7.2e-16 7.8e-04 83 PHACTR1
7 6 25285943 26689223 1 1 8.6e-08 6.9e-10 4.8e-06 45 U91328.21
8 6 95831017 97756290 5 2 2.5e-26 1.8e-31 1.2e-04 89 KIAA0776 UFL1
9 6 121106523 122500480 1 1 3.7e-09 7.2e-11 5.6e-03 82 RP1-172I22.1
10 9 70961350 72562779 2 1 5.7e-08 2.5e-09 8.9e-03 81 TJP2
11 11 56774260 58178587 1 1 6.5e-08 2.1e-06 9.6e-03 70 MED19
12 11 60465487 61861851 1 1 3.2e-07 7.5e-06 1.0e+00 100 TMEM216
13 12 55677395 58303535 6 2 1.6e-40 1.6e-40 1.0e+00 100 LRP1 RAB5B
14 12 109739011 111873167 8 2 2.4e-10 2.5e-10 1.0e+00 100 ANKRD13A FAM216A
15 12 111910219 113517494 1 1 2.8e-07 5.0e-07 3.5e-01 97 HECTD4
16 16 74578110 76197034 2 1 4.5e-08 3.7e-08 1.4e-01 93 TMEM170A
17 17 42607368 45796313 21 1 2.4e-18 1.7e-16 1.0e+00 100 CRHR1-IT1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Irritable Bowel Disease (IBD) 1.27 1 0 0.0 0.00 1.0e+00 ECM1
Reaction Time 2.29 2 1 3.0 0.00 1.0e+00 HECTD4 RAB5B
Verbal and Numeric Reasoning (VNR) 2.74 4 1 3.0 -0.26 7.4e-01 CRHR1-IT1 FAM216A RAB5B U91328.21
Breast Cancer 2.12 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Ovarian Cancer 3.06 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Coronary Artery Disease (CAD) 4.55 2 1 3.0 0.00 1.0e+00 HECTD4 PHACTR1
HDL Cholesterol 1.32 1 0 0.0 0.00 1.0e+00 AFF1
LDL Cholesterol 1.77 1 0 0.0 0.00 1.0e+00 HECTD4
Neuroticism 2.69 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Primary Biliary Cirrhosis 3.09 3 0 0.0 0.00 1.0e+00 CRHR1-IT1 HECTD4 LRP1
Schizophrenia 1.52 2 0 0.0 0.00 1.0e+00 CEP170 CRHR1-IT1
Triglycerides 1.84 1 1 3.0 0.00 1.0e+00 AFF1
Blood Eosinophil Count 5.83 6 5 15.2 0.62 1.9e-01 CRHR1-IT1 ECM1 HECTD4 LRP1 MED19 RAB5B
Blood Platelet Count 1.48 5 3 9.1 -0.58 3.1e-01 CRHR1-IT1 MED19 MEF2D TMEM170A UFL1
Blood Red Count 4.27 6 4 12.1 -0.20 7.1e-01 AFF1 CRHR1-IT1 HECTD4 MED19 RAB5B RP1-172I22.1
Blood White Count 2.90 4 2 6.1 0.65 3.5e-01 CRHR1-IT1 ECM1 HECTD4 RP1-172I22.1
Heel T-Score 1.87 6 3 9.1 -0.23 6.6e-01 AFF1 CRHR1-IT1 MED19 MEF2D RAB5B RP1-172I22.1
BMI 1.76 4 1 3.0 0.65 3.5e-01 CEP170 LRP1 MEF2D RAB5B
Height 0.82 8 5 15.2 0.04 9.2e-01 AFF1 CRHR1-IT1 ECM1 HECTD4 LRP1 MEF2D RARRES1 TMEM170A
Waist Hip Ratio (WHR) 1.82 2 2 6.1 0.00 1.0e+00 CRHR1-IT1 MEF2D
Systolic Blood Pressure 5.43 9 7 21.2 0.38 3.2e-01 ANKRD13A CRHR1-IT1 HECTD4 KIAA0776 MED19 MEF2D PHACTR1 TMEM170A UFL1
Smoking Status 1.49 1 1 3.0 0.00 1.0e+00 RAB5B
Allergy or Eczema 3.03 3 1 3.0 0.00 1.0e+00 LRP1 RAB5B TMEM170A
Cardiovascular Disease 2.11 4 1 3.0 0.47 5.3e-01 ANKRD13A HECTD4 RAB5B UFL1
Hypothyroidism (self reported) 4.81 3 2 6.1 0.00 1.0e+00 FAM216A HECTD4 RAB5B
Respiratory disease 4.24 4 2 6.1 0.23 7.7e-01 LRP1 RAB5B RP1-172I22.1 UFL1
Lung FEV1/FVC ratio 6.30 5 3 9.1 0.91 3.3e-02 CRHR1-IT1 LRP1 MEF2D RAB5B TMEM170A
Lung FVC 3.92 6 3 9.1 0.03 9.5e-01 AFF1 CRHR1-IT1 ECM1 MEF2D RAB5B RARRES1
Neuroticism 4.28 4 1 3.0 -0.98 2.1e-02 CEP170 CRHR1-IT1 MED19 TMEM216
Chronotype (morning person) 2.63 2 2 6.1 0.00 1.0e+00 ECM1 HECTD4
Hair Pigment 0.17 3 0 0.0 0.00 1.0e+00 CRHR1-IT1 HECTD4 LRP1
Tanning 0.30 1 0 0.0 0.00 1.0e+00 ECM1
Hand grip strength (left) 2.01 2 2 6.1 0.00 1.0e+00 CRHR1-IT1 ECM1
Number of treatments/medications taken 3.71 2 0 0.0 0.00 1.0e+00 LRP1 MEF2D
Sensitivity / hurt feelings 4.06 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Frequency of depressed mood in last 2 weeks 2.87 2 0 0.0 0.00 1.0e+00 CRHR1-IT1 MED19
Relative age of first facial hair 3.23 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Systolic blood pressure, automated reading 4.74 8 5 15.2 -0.37 3.7e-01 ANKRD13A CRHR1-IT1 HECTD4 KIAA0776 MED19 PHACTR1 TMEM170A UFL1
Angina 3.09 1 0 0.0 0.00 1.0e+00 PHACTR1
Vitamin and mineral supplements 2.54 1 1 3.0 0.00 1.0e+00 LRP1
Impedance of leg (right) 1.03 2 1 3.0 0.00 1.0e+00 CRHR1-IT1 RAB5B
Leg fat-free mass (left) 0.93 2 1 3.0 0.00 1.0e+00 HECTD4 RAB5B
Trunk fat percentage 1.48 4 1 3.0 -0.15 8.5e-01 CEP170 CRHR1-IT1 MED19 TMEM216
Hand grip strength (right) 2.23 3 2 6.1 0.00 1.0e+00 CRHR1-IT1 ECM1 LRP1
Fed-up feelings 3.71 3 1 3.0 0.00 1.0e+00 CRHR1-IT1 HECTD4 TMEM216
Relative age voice broke 2.40 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Age when periods started (menarche) 1.42 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
High blood pressure 3.33 4 2 6.1 -0.26 7.4e-01 ANKRD13A HECTD4 RAB5B UFL1
Hayfever, allergic rhinitis or eczema 2.54 2 1 3.0 0.00 1.0e+00 LRP1 RAB5B
Multivitamins +/- minerals 1.67 1 0 0.0 0.00 1.0e+00 LRP1
Medication: Atenolol 2.12 1 0 0.0 0.00 1.0e+00 HECTD4
Medication: Levothyroxine sodium 4.33 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Sitting height 1.31 3 2 6.1 0.00 1.0e+00 CRHR1-IT1 ECM1 LRP1
High blood pressure (mother) 2.79 2 0 0.0 0.00 1.0e+00 PHACTR1 TMEM170A
Body mass index (BMI) 1.53 3 1 3.0 0.00 1.0e+00 CEP170 HECTD4 RAB5B
Impedance of leg (left) 1.07 2 2 6.1 0.00 1.0e+00 CRHR1-IT1 RAB5B
Leg predicted mass (left) 0.92 2 1 3.0 0.00 1.0e+00 HECTD4 RAB5B
Trunk fat mass 1.33 3 0 0.0 0.00 1.0e+00 CEP170 HECTD4 MED19
Waist circumference 1.31 2 0 0.0 0.00 1.0e+00 HECTD4 RAB5B
Past tobacco smoking 1.52 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Nervous feelings 2.51 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Frequency of tenseness / restlessness in last 2 weeks 3.84 2 1 3.0 0.00 1.0e+00 CRHR1-IT1 TMEM216
Hearing difficulty/problems with background noise 1.56 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Hair/balding pattern: Pattern 2 1.84 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Forced vital capacity (FVC) 2.88 3 2 6.1 0.00 1.0e+00 CRHR1-IT1 RAB5B U91328.21
Heel bone mineral density (BMD) T-score, automated (right) 1.40 1 0 0.0 0.00 1.0e+00 AFF1
Ever unenthusiastic/disinterested for a whole week 1.84 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Qualifications: None of the above 2.54 1 1 3.0 0.00 1.0e+00 RAB5B
Mouth/teeth dental problems 2.12 2 0 0.0 0.00 1.0e+00 CEP170 CRHR1-IT1
Heart attack 3.02 1 1 3.0 0.00 1.0e+00 PHACTR1
Allergy 3.05 2 1 3.0 0.00 1.0e+00 LRP1 RAB5B
Hayfever/allergic rhinitis (self-reported) 2.08 2 0 0.0 0.00 1.0e+00 LRP1 RAB5B
Fluid intelligence score 2.89 3 0 0.0 0.00 1.0e+00 CRHR1-IT1 RAB5B U91328.21
Neuroticism score 4.11 3 1 3.0 0.00 1.0e+00 CRHR1-IT1 MED19 TMEM216
Weight 1.24 3 2 6.1 0.00 1.0e+00 CEP170 HECTD4 RAB5B
Impedance of arm (right) 2.06 4 2 6.1 -0.98 1.6e-02 AFF1 CRHR1-IT1 RAB5B TMEM216
Arm fat percentage (right) 1.52 1 0 0.0 0.00 1.0e+00 MED19
Trunk fat-free mass 0.99 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Hip circumference 1.30 3 1 3.0 0.00 1.0e+00 CEP170 HECTD4 RAB5B
Worrier / anxious feelings 1.89 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Frequency of tiredness / lethargy in last 2 weeks 2.97 2 1 3.0 0.00 1.0e+00 HECTD4 MED19
Hair/balding pattern: Pattern 3 3.11 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Number of live births 1.64 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Forced expiratory volume in 1-second (FEV1) 3.95 5 3 9.1 0.10 8.8e-01 CRHR1-IT1 ECM1 RAB5B TMEM170A U91328.21
Qualifications: A levels/AS levels or equivalent 2.31 3 1 3.0 0.00 1.0e+00 CEP170 CRHR1-IT1 RAB5B
Asthma 4.10 3 1 3.0 0.00 1.0e+00 LRP1 RAB5B U91328.21
Medication: Ibuprofen (e.g. Nurofen) 10.21 8 1 3.0 0.95 3.1e-04 CRHR1-IT1 HECTD4 KIAA0776 LRP1 MEF2D PHACTR1 TJP2 U91328.21
Forced expiratory volume in 1-second (FEV1), Best measure 3.63 4 3 9.1 -1.00 4.8e-03 CRHR1-IT1 RAB5B TMEM170A U91328.21
Impedance of arm (left) 2.24 3 2 6.1 0.00 1.0e+00 CRHR1-IT1 RAB5B TMEM216
Arm fat mass (right) 1.53 4 1 3.0 0.98 1.7e-02 CEP170 HECTD4 MED19 RAB5B
Trunk predicted mass 1.01 3 2 6.1 0.00 1.0e+00 HECTD4 LRP1 RAB5B
Standing height 0.77 5 2 6.1 0.53 3.5e-01 CRHR1-IT1 HECTD4 LRP1 TMEM170A U91328.21
Seen doctor (GP) for nerves, anxiety, tension or depression 1.87 1 0 0.0 0.00 1.0e+00 U91328.21
Hair/balding pattern: Pattern 4 5.23 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Birth weight of first child 2.73 3 1 3.0 0.00 1.0e+00 HECTD4 RAB5B TMEM170A
Peak expiratory flow (PEF) 3.05 4 2 6.1 0.22 7.8e-01 CRHR1-IT1 ECM1 TMEM170A U91328.21
Medication: Paracetamol 12.27 9 6 18.2 0.60 8.6e-02 CEP170 CRHR1-IT1 KIAA0776 LRP1 MEF2D PHACTR1 RAB5B U91328.21 UFL1
Hypothyroidism/myxoedema (self-reported) 4.33 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Medication: Ventolin 100micrograms inhaler 2.21 1 0 0.0 0.00 1.0e+00 RAB5B
Forced vital capacity (FVC), Best measure 2.62 3 2 6.1 0.00 1.0e+00 CRHR1-IT1 RAB5B U91328.21
Body fat percentage 1.50 4 0 0.0 -0.21 7.9e-01 CEP170 LRP1 MED19 TMEM216
Leg fat percentage (right) 1.63 2 0 0.0 0.00 1.0e+00 HECTD4 LRP1
Arm fat-free mass (right) 0.95 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Comparative body size at age 10 1.05 1 0 0.0 0.00 1.0e+00 U91328.21
Number of full brothers 2.25 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Worry too long after embarrassment 2.31 2 1 3.0 0.00 1.0e+00 CRHR1-IT1 MED19
Age at first live birth 2.25 1 0 0.0 0.00 1.0e+00 RAB5B
Qualifications: College or University degree 2.81 3 3 9.1 0.00 1.0e+00 CEP170 CRHR1-IT1 RAB5B
Medication for pain relief, constipation, heartburn 11.41 8 6 18.2 -0.41 3.2e-01 CEP170 CRHR1-IT1 KIAA0776 LRP1 MEF2D PHACTR1 U91328.21 UFL1
Angina (self-reported) 3.04 1 1 3.0 0.00 1.0e+00 PHACTR1
Migraine (self-reported) 14.04 8 6 18.2 0.99 4.6e-06 AFF1 ECM1 KIAA0776 LRP1 MEF2D PHACTR1 RP1-172I22.1 UFL1
Medication: Ibuprofen 7.80 4 1 3.0 0.95 5.3e-02 CRHR1-IT1 LRP1 MEF2D PHACTR1
Mean time to correctly identify matches 2.01 1 1 3.0 0.00 1.0e+00 HECTD4
Heart disease (mother) 2.24 1 0 0.0 0.00 1.0e+00 HECTD4
Whole body fat mass 1.39 3 0 0.0 0.00 1.0e+00 CEP170 HECTD4 RAB5B
Leg fat mass (right) 1.53 3 0 0.0 0.00 1.0e+00 CEP170 HECTD4 RAB5B
Arm predicted mass (right) 1.00 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Pulse rate, automated reading 1.81 2 1 3.0 0.00 1.0e+00 MEF2D RAB5B
Alcohol intake frequency. 3.41 4 1 3.0 0.90 1.0e-01 CRHR1-IT1 LRP1 MED19 RAB5B
Comparative height size at age 10 1.32 3 3 9.1 0.00 1.0e+00 CRHR1-IT1 HECTD4 U91328.21
Overall health rating 1.98 1 1 3.0 0.00 1.0e+00 CEP170
Medication: Aspirin 1.59 1 0 0.0 0.00 1.0e+00 MEF2D
Hypertension (Self-reported) 3.16 5 1 3.0 -0.25 6.9e-01 ANKRD13A HECTD4 RAB5B RP1-172I22.1 UFL1
Illnesses of father: Heart disease 2.03 1 0 0.0 0.00 1.0e+00 PHACTR1
Smoking status: Previous 1.87 2 0 0.0 0.00 1.0e+00 HECTD4 RAB5B
Whole body fat-free mass 0.97 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Leg fat-free mass (right) 0.87 2 1 3.0 0.00 1.0e+00 HECTD4 RAB5B
Arm fat percentage (left) 1.39 1 0 0.0 0.00 1.0e+00 MED19
Average weekly red wine intake 2.25 1 0 0.0 0.00 1.0e+00 MED19
Handedness (chirality/laterality): Left-handed 1.63 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Mood swings 3.82 2 1 3.0 0.00 1.0e+00 CRHR1-IT1 TMEM216
Loneliness, isolation 2.94 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Mouth/teeth dental problems: Mouth ulcers 2.77 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Medication: Laxatives (e.g. Dulcolax, Senokot) 1.38 1 0 0.0 0.00 1.0e+00 ECM1
Back pain experienced in last month 2.00 1 0 0.0 0.00 1.0e+00 HECTD4
Mineral and other dietary supplements 2.06 1 0 0.0 0.00 1.0e+00 LRP1
Asthma (self-reported) 4.15 4 1 3.0 0.47 5.3e-01 LRP1 RAB5B U91328.21 UFL1
Medication: Aspirin 1.48 1 0 0.0 0.00 1.0e+00 MEF2D
Forced expiratory volume in 1-second (FEV1), predicted percentage 4.50 5 3 9.1 0.21 7.4e-01 CRHR1-IT1 ECM1 RAB5B TMEM170A U91328.21
Whole body water mass 0.99 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Leg predicted mass (right) 0.87 2 1 3.0 0.00 1.0e+00 HECTD4 RAB5B
Arm fat mass (left) 1.41 3 1 3.0 0.00 1.0e+00 CEP170 HECTD4 RAB5B
Average weekly champagne plus white wine intake 2.70 1 0 0.0 0.00 1.0e+00 CRHR1-IT1
Miserableness 2.80 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Guilty feelings 2.93 2 0 0.0 0.00 1.0e+00 CRHR1-IT1 MED19
Medication: Blood pressure 2.52 2 0 0.0 0.00 1.0e+00 CRHR1-IT1 HECTD4
Supplements: Fish oil (including cod liver oil) 2.13 1 0 0.0 0.00 1.0e+00 LRP1
Medication: Paracetamol 9.38 7 3 9.1 0.62 1.4e-01 CEP170 CRHR1-IT1 KIAA0776 LRP1 PHACTR1 U91328.21 UFL1
Basal metabolic rate 1.04 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Leg fat percentage (left) 1.58 2 0 0.0 0.00 1.0e+00 CEP170 LRP1
Arm fat-free mass (left) 1.18 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B
Irritability 2.29 1 1 3.0 0.00 1.0e+00 CRHR1-IT1
Ever had prostate specific antigen (PSA) test 2.05 1 0 0.0 0.00 1.0e+00 U91328.21
Age started oral contraceptive pill 1.89 1 0 0.0 0.00 1.0e+00 RAB5B
Diastolic blood pressure, automated reading 3.91 4 3 9.1 -0.23 7.7e-01 CEP170 HECTD4 RP1-172I22.1 U91328.21
Myopia 1.93 1 0 0.0 0.00 1.0e+00 LRP1
Vascular/heart problems diagnosed by doctor 2.84 4 0 0.0 0.20 8.0e-01 ANKRD13A HECTD4 MEF2D UFL1
Pain experienced in last month 7.45 7 2 6.1 -0.95 1.1e-03 CEP170 CRHR1-IT1 HECTD4 LRP1 PHACTR1 RAB5B UFL1
Heart attack/myocardial infarction (self-reported) 3.08 1 1 3.0 0.00 1.0e+00 PHACTR1
Impedance of whole body 1.72 2 2 6.1 0.00 1.0e+00 CRHR1-IT1 RAB5B
Leg fat mass (left) 1.52 3 1 3.0 0.00 1.0e+00 CEP170 HECTD4 RAB5B
Arm predicted mass (left) 1.21 2 2 6.1 0.00 1.0e+00 HECTD4 RAB5B

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 11 0.3151 1.79
GTEx Adipose Visceral Omentum 9 0.4420 1.84
GTEx Adrenal Gland 7 0.4804 1.88
GTEx Artery Aorta 13 0.4367 1.91
GTEx Artery Coronary 10 0.8453 2.16
GTEx Artery Tibial 19 0.5052 1.97
GTEx Brain Caudate basal ganglia 5 0.5435 1.80
GTEx Brain Cerebellar Hemisphere 8 0.5373 1.88
GTEx Brain Cerebellum 6 0.3027 1.76
GTEx Brain Cortex 6 0.5797 1.85
GTEx Brain Frontal Cortex BA9 5 0.5411 1.98
GTEx Brain Hippocampus 6 1.1450 2.29
GTEx Brain Hypothalamus 4 0.6780 1.93
GTEx Brain Nucleus accumbens basal ganglia 6 0.6936 1.88
GTEx Brain Putamen basal ganglia 5 0.8013 1.87
GTEx Breast Mammary Tissue 8 0.4053 1.84
GTEx Breast Mammary Tissue (Male) 7 0.5868 1.98
GTEx Breast Mammary Tissue (Female) 10 0.6083 1.80
GTEx Cells EBV-transformed lymphocytes 9 0.6325 2.07
GTEx Cells Transformed fibroblasts 15 0.3572 1.80
GTEx Colon Sigmoid 7 0.4788 1.91
GTEx Colon Transverse 9 0.4360 1.89
GTEx Esophagus Gastroesophageal Junction 8 0.5536 1.87
GTEx Esophagus Mucosa 15 0.4518 1.80
GTEx Esophagus Muscularis 13 0.4022 1.79
GTEx Heart Atrial Appendage 7 0.4433 1.83
GTEx Heart Left Ventricle 8 0.5229 1.74
GTEx Liver 4 0.5579 1.77
GTEx Lung 9 0.3133 1.79
GTEx Muscle Skeletal 11 0.3806 1.80
GTEx Nerve Tibial 12 0.2777 1.77
GTEx Ovary 6 0.6608 2.03
GTEx Pancreas 9 0.5515 1.95
GTEx Pituitary 5 0.4484 1.84
GTEx Prostate 6 0.7186 1.88
GTEx Skin Not Sun Exposed Suprapubic 11 0.4473 1.93
GTEx Skin Sun Exposed Lower leg 11 0.3022 1.83
GTEx Small Intestine Terminal Ileum 4 0.8677 2.07
GTEx Spleen 5 0.3544 1.86
GTEx Stomach 7 0.4814 1.88
GTEx Testis 11 0.3487 1.84
GTEx Thyroid 12 0.3001 1.83
GTEx Uterus 6 1.0582 2.29
GTEx Vagina 5 0.7874 1.99
GTEx Whole Blood 7 0.3512 1.71
METSIM Adipose 5 0.1085 1.57
NTR Blood 7 0.2914 1.68
ROSMAP Brain Pre-frontal Cortex 2 0.0455 1.54
YFS Blood 4 0.0866 1.50
CommonMind Brain Pre-frontal Cortex 8 0.1488 1.60
TCGA Breast Tumor 3 0.3911 1.78
TCGA Breast Normal 3 0.0713 1.46
TCGA Ovarian Tumor 6 0.2053 1.49
TCGA Prostate Tumor 5 0.1446 1.61